BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 22510212)

  • 1. Role of perferryl-oxo oxidant in alkane hydroxylation catalyzed by cytochrome P450: a hybrid density functional study.
    Isobe H; Yamaguchi K; Okumura M; Shimada J
    J Phys Chem B; 2012 Apr; 116(16):4713-30. PubMed ID: 22510212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique structural and electronic features of perferryl-oxo oxidant in Cytochrome P450.
    Isobe H; Yamanaka S; Okumura M; Yamaguchi K; Shimada J
    J Phys Chem B; 2011 Sep; 115(36):10730-8. PubMed ID: 21812482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Density functional theory applied to a difference in pathways taken by the enzymes cytochrome P450 and superoxide reductase: spin States of ferric hydroperoxo intermediates and hydrogen bonds from water.
    Surawatanawong P; Tye JW; Hall MB
    Inorg Chem; 2010 Jan; 49(1):188-98. PubMed ID: 19968237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the ruthenium analogue of compound I of cytochrome p450 an efficient oxidant? A theoretical investigation of the methane hydroxylation reaction.
    Sharma PK; De Visser SP; Ogliaro F; Shaik S
    J Am Chem Soc; 2003 Feb; 125(8):2291-300. PubMed ID: 12590559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ortho-Hydroxylation of aromatic acids by a non-heme Fe(V)=O species: how important is the ligand design?
    Ansari A; Rajaraman G
    Phys Chem Chem Phys; 2014 Jul; 16(28):14601-13. PubMed ID: 24812659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundamental differences of substrate hydroxylation by high-valent iron(IV)-oxo models of cytochrome P450.
    Tahsini L; Bagherzadeh M; Nam W; de Visser SP
    Inorg Chem; 2009 Jul; 48(14):6661-9. PubMed ID: 19469505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights on the ortho-hydroxylation of aromatic compounds by non-heme iron complex: a computational case study on the comparative oxidative ability of ferric-hydroperoxo and high-valent Fe(IV)═O and Fe(V)═O intermediates.
    Ansari A; Kaushik A; Rajaraman G
    J Am Chem Soc; 2013 Mar; 135(11):4235-49. PubMed ID: 23373840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A density functional study on a biomimetic non-heme iron catalyst: insights into alkane hydroxylation by a formally HO-FeV=O oxidant.
    Bassan A; Blomberg MR; Siegbahn PE; Que L
    Chemistry; 2005 Jan; 11(2):692-705. PubMed ID: 15580652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The valence bond way: reactivity patterns of cytochrome P450 enzymes and synthetic analogs.
    Shaik S; Lai W; Chen H; Wang Y
    Acc Chem Res; 2010 Aug; 43(8):1154-65. PubMed ID: 20527755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkane hydroxylation by peroxy acids: a comparison with the cytochrome P450 hydroxylation.
    Groenhof AR; Ehlers AW; Lammertsma K
    J Phys Chem A; 2008 Dec; 112(50):12855-61. PubMed ID: 18956858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in substrate hydroxylation reactions by heme and nonheme iron(IV)-oxo oxidants give correlations between intrinsic properties of the oxidant with barrier height.
    de Visser SP
    J Am Chem Soc; 2010 Jan; 132(3):1087-97. PubMed ID: 20041691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propene activation by the oxo-iron active species of taurine/alpha-ketoglutarate dioxygenase (TauD) enzyme. How does the catalysis compare to heme-enzymes?
    de Visser SP
    J Am Chem Soc; 2006 Aug; 128(30):9813-24. PubMed ID: 16866538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A theoretical study on the mechanism of camphor hydroxylation by compound I of cytochrome p450.
    Kamachi T; Yoshizawa K
    J Am Chem Soc; 2003 Apr; 125(15):4652-61. PubMed ID: 12683838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gauging the relative oxidative powers of compound I, ferric-hydroperoxide, and the ferric-hydrogen peroxide species of cytochrome P450 toward C-H hydroxylation of a radical clock substrate.
    Derat E; Kumar D; Hirao H; Shaik S
    J Am Chem Soc; 2006 Jan; 128(2):473-84. PubMed ID: 16402834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome p450 enzymes.
    de Visser SP; Shaik S
    J Am Chem Soc; 2003 Jun; 125(24):7413-24. PubMed ID: 12797816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical study of the mechanism of alkane hydroxylation and ethylene epoxidation reactions catalyzed by diiron bis-oxo complexes. The effect of substrate molecules.
    Musaev DG; Basch H; Morokuma K
    J Am Chem Soc; 2002 Apr; 124(15):4135-48. PubMed ID: 11942853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the active species of cytochrome P450 during camphor hydroxylation? QM/MM studies of different electronic states of compound I and of reduced and oxidized iron-oxo intermediates.
    Altun A; Shaik S; Thiel W
    J Am Chem Soc; 2007 Jul; 129(29):8978-87. PubMed ID: 17595079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the axial ligand on substrate sulfoxidation mediated by iron(IV)-oxo porphyrin cation radical oxidants.
    Kumar D; Sastry GN; de Visser SP
    Chemistry; 2011 May; 17(22):6196-205. PubMed ID: 21469227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Models and mechanisms of O-O bond activation by cytochrome P450. A critical assessment of the potential role of multiple active intermediates in oxidative catalysis.
    Hlavica P
    Eur J Biochem; 2004 Nov; 271(22):4335-60. PubMed ID: 15560776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What factors influence the rate constant of substrate epoxidation by compound I of cytochrome P450 and analogous iron(IV)-oxo oxidants?
    Kumar D; Karamzadeh B; Sastry GN; de Visser SP
    J Am Chem Soc; 2010 Jun; 132(22):7656-67. PubMed ID: 20481499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.